Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
06/22 EDWARDS LIFESCIENCES : "Knotless Suture Fastener Installation System" in Patent ..
06/22 EDWARDS LIFESCIENCES : Patent Issued for Methods of Identifying and Replacing Im..
06/21 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Ju..
06/19 EDWARDS LIFESCIENCES : Technical Reports on Medical Equipment Equities -- Hologi..
06/17 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Ju..
06/15 EDWARDS LIFESCIENCES : Trademark Application for "ENCIRCLE" Filed by Edwards Lif..
06/15 EDWARDS LIFESCIENCES : Patent Issued for Self-Cinching Surgical Clips and Delive..
06/13 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Ju..
06/09 EDWARDS LIFESCIENCES : Patent Issued for Transapical Method of Delivering Prosth..
06/09 EDWARDS LIFESCIENCES' : Trademark Application for "VIGILEO" Filed
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/16 Neovasc loses court case in Germany over Tiara patent; shares down 16%
06/09 SNIPPET ROUNDUP : Shire's Lialda Goes Generic And Novartis Whets CAR-T Appetites
06/05 Edwards' Sapien 3 valve OK'd in U.S. for valve-in-valve treatment
05/26 BofA/Merrill Lynch bullish on Edwards Lifesciences; sees 22% upside
05/16 Lotus Blooms In Phase III
Advertisement
Financials ($)
Sales 2017 3 349 M
EBIT 2017 1 006 M
Net income 2017 777 M
Finance 2017 472 M
Yield 2017 -
P/E ratio 2017 33,51
P/E ratio 2018 30,38
EV / Sales 2017 7,39x
EV / Sales 2018 6,65x
Capitalization 25 208 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 122 $
Spread / Average Target 1,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John T. Cardis Independent Director
William J. Link Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..28.23%25 208
THERMO FISHER SCIENTIF..23.63%68 244
DANAHER10.05%60 686
BOSTON SCIENTIFIC CORP..29.91%38 480
INTUITIVE SURGICAL49.64%34 960
ROYAL PHILIPS13.22%34 550
More Results